Key result
Patients with primary cutaneous Ewing sarcoma had an estimated 10-year survival probability of 91%, demonstrating a better outcome compared to Ewing sarcoma of the bone.
Why the study?
What are the epidemiological and prognostic characteristics of primary cutaneous Ewing sarcoma?
Systematic Review (n=61)
What are the epidemiological and prognostic characteristics of primary cutaneous Ewing sarcoma?
Primary cutaneous Ewing sarcoma has a better prognosis than Ewing sarcoma of the bone, suggesting a less toxic treatment approach may be warranted.
Answers are grounded in this paper and cite their sources.
Supports favorable prognosis counseling in cutaneous Ewing sarcoma; extends site-specific survival benchmarks beyond osseous disease.
BACKGROUND: Despite intensive treatment, the overall prognosis of Ewing sarcoma of the bone remains poor. Primary cutaneous Ewing sarcoma very rarely occurs and the prognosis has been reported to be better in some small series. All cases of Ewing sarcoma are currently treated in the same way, regardless of their location. OBJECTIVES: To determine whether Ewing sarcoma of the bone and primary cutaneous Ewing sarcoma are different in terms of epidemiology and prognosis. METHODS: A systematic review of the literature was carried out using the keywords 'cutaneous Ewing's sarcoma', 'primary Ewing's sarcoma of skin' and 'primary neuroectodermal tumour and skin' in the Medline database. Series of five or more cases were included. RESULTS: Six series met the inclusion criteria, making a total of 61 patients. Median age at diagnosis was 17 years and 33% were male. The median size of the tumour was 2·3 cm. The treatment consisted of surgery in all cases, adjuvant multiagent chemotherapy in 69% of cases, adjuvant chemoradiotherapy in 38% of cases and adjuvant radiotherapy without adjuvant chemotherapy in 3% of cases. Six patients developed metastases, four of whom died. The overall survival was 93% and the 10-year probability of survival was estimated at 91% (95% confidence interval 83-100). CONCLUSION: This systematic review demonstrated epidemiological and prognostic differences between Ewing sarcoma of the bone and primary cutaneous Ewing sarcoma. Primary cutaneous Ewing sarcoma has a female predominance, occurs at a later age, but, more importantly, has a better outcome. Multimodal therapy for Ewing sarcoma is associated with immediate and long-term morbidity and mortality. Although the size of our study does not allow a definitive conclusion about treatment modalities, we suggest that a less toxic approach compared with conventional treatment should be investigated in primary cutaneous Ewing sarcoma.
No takes yet. Share an insight, caveat, or question.
Delaplace et al. (2011) conducted a systematic review in Primary cutaneous Ewing sarcoma (n=61). Primary cutaneous Ewing sarcoma vs. Ewing sarcoma of the bone was evaluated on 10-year probability of survival (95% CI 83-100). Patients with primary cutaneous Ewing sarcoma had an estimated 10-year survival probability of 91%, demonstrating a better outcome compared to Ewing sarcoma of the bone.
Synapse has enriched 10 related papers. Consider them for comparative context: